DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation (OTC QB:CONX.OB), a worldwide developer and marketer of diagnostic test kits, today filed its third quarter Form 10-Q and reported its financial results. Some of the results highlighted by the report are as follows:
